| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219941 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
Poor baseline PFT did not appear to predict pulmonary toxicity or decreased overall survival after SBRT in this medically inoperable population. Poor baseline PFT alone should not be used to exclude patients with early stage lung cancer from treatment with SBRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sinisa MD, Rebecca BS, Robert D. MD, Jeff M. MD, Robert B. MD, Andrea MD, Gregory M.M. MD, Jeffrey MD,